🇺🇸 FDA
Pipeline program

GV-971

GV971-007

Phase 3 small_molecule on_hold

Quick answer

GV-971 for Alzheimer Disease is a Phase 3 program (small_molecule) at Shanghai University of Traditional Chinese Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Shanghai University of Traditional Chinese Medicine
Indication
Alzheimer Disease
Phase
Phase 3
Modality
small_molecule
Status
on_hold

Clinical trials